Sponsored diagnostic testing programs for ALG6-Congenital Disorder of Glycosylation (CDG-Ic)
ALG6-congenital disorder of glycosylation (ALG6-CDG, CDG-Ic) is a rare inherited disorder of protein glycosylation that can affect multiple organ systems. Common features include developmental delay, hypotonia, feeding difficulties, seizures, and liver involvement, though severity varies widely. Genetic testing confirms the diagnosis and helps guide management and family counseling.
1 program found for ALG6-Congenital Disorder of Glycosylation (CDG-Ic)
This program provides access to genetic testing for pediatric patients under 18 who present with an unprovoked seizure. The panel evaluates key epilepsy-associated genes to support diagnostic confirmation, inform prognosis, and guide clinical management. Testing is available to eligible patients when ordered by a licensed healthcare provider.
